Singapore markets closed

Organogenesis Holdings Inc. (ORGO)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
2.6500-0.0600 (-2.21%)
At close: 04:00PM EST
2.6500 0.00 (0.00%)
After hours: 04:01PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 354.78M
Enterprise value 378.24M
Trailing P/E 6.02
Forward P/E 12.32
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)0.78
Price/book (mrq)1.38
Enterprise value/revenue 0.82
Enterprise value/EBITDA 7.23

Trading information

Stock price history

Beta (5Y monthly) 1.55
52-week change 3-71.83%
S&P500 52-week change 3-15.73%
52-week high 310.3900
52-week low 32.2300
50-day moving average 33.0268
200-day moving average 35.0917

Share statistics

Avg vol (3-month) 3728.61k
Avg vol (10-day) 3432.67k
Shares outstanding 5130.91M
Implied shares outstanding 6N/A
Float 858.6M
% held by insiders 150.58%
% held by institutions 143.27%
Shares short (14 Nov 2022) 45.93M
Short ratio (14 Nov 2022) 49.82
Short % of float (14 Nov 2022) 417.29%
Short % of shares outstanding (14 Nov 2022) 44.53%
Shares short (prior month 13 Oct 2022) 45.68M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Sept 2022

Profitability

Profit margin 12.88%
Operating margin (ttm)9.14%

Management effectiveness

Return on assets (ttm)6.40%
Return on equity (ttm)26.82%

Income statement

Revenue (ttm)463.94M
Revenue per share (ttm)3.58
Quarterly revenue growth (yoy)2.70%
Gross profit (ttm)353.86M
EBITDA 53.37M
Net income avi to common (ttm)59.74M
Diluted EPS (ttm)0.4300
Quarterly earnings growth (yoy)-98.30%

Balance sheet

Total cash (mrq)108.1M
Total cash per share (mrq)0.83
Total debt (mrq)130.71M
Total debt/equity (mrq)50.99
Current ratio (mrq)2.58
Book value per share (mrq)1.96

Cash flow statement

Operating cash flow (ttm)35.01M
Levered free cash flow (ttm)17.38M